Encision Inc 最大收入来源是 Patented Surgical Instruments,在最近的收益报告中收入为 6,217,687。就地区而言, United States 是 Encision Inc 的主要市场,收入为 6,555,315。
Encision Inc 是否盈利?
否,根据最新的财务报表,Encision Inc 的净亏损为 $0
Encision Inc 有负债吗?
否,Encision Inc 的负债为 0
Encision Inc 的流通股有多少?
Encision Inc 的总流通股为 0
关键数据
前收盘价
$0.0015
开盘价
$0.2
当日区间
$0.0015 - $0.201
52周范围
$0.0002 - $0.4
交易量
13.3K
平均成交量
14.0K
股息收益率
--
每股收益(TTM)
-0.03
市值
$25.3K
什么是 ECIA?
Encision, Inc. is a medical device company, which engages in the designing, developing, and manufacturing of patented surgical instruments in the United States. The company is headquartered in Boulder, Colorado and currently employs 22 full-time employees. The company designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. The Product segment designs, develops, manufactures and markets patented surgical instruments. The Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause tissue injury that may result in death. The AEM system consists of shielded 5mm AEM Instruments and an AEM monitor. Laparoscopic instruments have the integrated AEM design and include the full range of instruments that are common in laparoscopic surgery. The AEM monitor is compatible with electrosurgical generators.